Ticker
VRCACompany Name
VERRICA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Liabilities | Working Capital |
---|---|---|---|
6/30/2025 | $ 36.78M | $ 29.22M | $ 7.56M |
3/31/2025 | $ 39.47M | $ 29.4M | $ 10.08M |
12/31/2024 | $ 51.18M | $ 29.01M | $ 22.17M |
9/30/2024 | $ 28.19M | $ 21.03M | $ 7.16M |
6/30/2024 | $ 47.32M | $ 20.05M | $ 27.27M |
3/31/2024 | $ 61.38M | $ 19.36M | $ 42.01M |
12/31/2023 | $ 77.53M | $ 17.02M | $ 60.51M |
9/30/2023 | $ 91.72M | $ 11.37M | $ 80.35M |
6/30/2023 | $ 56.78M | $ 5.73M | $ 51.05M |
3/31/2023 | $ 63.1M | $ 2.64M | $ 60.45M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for VERRICA PHARMACEUTICALS INC is calculated as follows: AssetsC [ $ 73.97M ] - LiabilitesC [ $ 39M ]
(=) Working Capital [ $ 34.97M ]
Minimum
Sep 30, 2024
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 2.78K |
---|---|
min | $ -465.2M |
max | $ 607.04M |
average | $ 96.5M |
median | $ 32.21M |
std | $ 173.86M |